# Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children

> **NCT01065259** · PHASE4 · COMPLETED · sponsor: **Peking University** · enrollment: 262 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** OROS MPH
- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT01065259
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065259, "Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01065259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*